Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam besylate for anesthesia management in ERCP
ChiCTR2200059783Phase 4Recruiting
- Sponsor
- Zunyi Medical University Affiliated Hospital
- Start
- Apr 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of remimazolam, sponsored by Zunyi Medical University Affiliated Hospital. Primary endpoint: Effective sedative dose of remimazolam besylate. Started Apr 2022; status: recruiting.
02
Drugs
remimazolam
Beyond the preview
Go deeper on ChiCTR2200059783.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200059783.